Advertisements



We are Sorry, This Page doesn't Exist


IPO News This Week: Two Solid Offerings on Tap

The two IPOs on this week's calendar include one tech unicorn and a biotech working on a treatment from Alzheimer disease......»»

Category: blogSource: 247wallstApr 8th, 2018

DIGITAL HEALTH BRIEFING: Chatbot patient engagement platform raises $6 million — Telehealth saves insurers $1.5 million — UK bets on AI for chronic disease treatment

Welcome to Digital Health Briefing, th.....»»

Category: topSource: businessinsiderMay 23rd, 2018

Why Cara Therapeutics Shares Are Soaring

Cara Therapeutics shares made a solid gain on Wednesday after the firm announced that it has licensed rights to commercialize Korsuva injection for the treatment of chronic kidney disease-associated........»»

Category: blogSource: 247wallstMay 23rd, 2018

Spark, Pfizer report progress on gene therapy for hemophilia

Spark Therapeutcis and Pfizer have cleared a key hurdle in their effort to develop a gene therapy treatment for patient with hemophilia B. On Tuesday, the companies said all 15 hemophilia B patients in Philadelphia-based Spark’s ongoing phase-I.....»»

Category: topSource: bizjournalsMay 22nd, 2018

Johnson & Johnson scraps Alzheimer"s trials on safety concerns

Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease......»»

Category: topSource: moneycentralMay 18th, 2018

Johnson & Johnson scraps Alzheimer"s trials on safety concerns

Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease......»»

Category: topSource: moneycentralMay 18th, 2018

This Mutation Protects Mice From Alzheimer"s Disease; Could It Work on Humans?

A similar mutation was found in a small population of humans, and may have the same protective effect......»»

Category: topSource: newsweekMay 17th, 2018

Too Much Iron May Act Like Rust in the Brain, Is Linked to Alzheimer’s Disease

Addressing this excess iron could be an effective treatment option......»»

Category: topSource: newsweekMay 8th, 2018

According To Science You Are More Likely To Develop Heart Disease If This One Thing Is Missing At Work

Change this behavior before it's too late.....»»

Category: topSource: incMay 7th, 2018

Amazon Wants to Know Your Waistline

Online retailer Amazon.com is inviting people to track changes in their body size and shape over 20 weeks, as part of its quest to develop technology for predicting how clothing will fit......»»

Category: smallbizSource: wsjMay 3rd, 2018

Genzyme granted orphan status for polycystic kidney disease treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 3rd, 2018

Eating a Mediterranean Diet Could Offer Delay Alzheimer’s Disease by Years

Here's a tasty way to reduce your Alzheimer's disease risk......»»

Category: topSource: newsweekMay 3rd, 2018

Amazon Studies Body Sizes to Get That Perfect Clothing Fit

Online retailer Amazon.com is inviting people to track changes in their body size and shape over 20 weeks, as part of its quest to develop technology for predicting how clothing will fit......»»

Category: smallbizSource: wsjMay 3rd, 2018

Biogen will pay $50 million to reduce royalties on Alzheimer"s disease drug

Biogen Inc. said early Tuesday that it will pay $50 million to privately-held Neurimmune to reduce royalty rates on the late-stage Alzheimer's disease drug aducanumab. The 5% reduction will leave royalty rates on potenti.....»»

Category: topSource: marketwatchMay 1st, 2018

Malaria Death Rates Are Still High Because of Fake Drugs | Opinion

If malaria is a curable disease with effective treatment, why does it still kill so many?.....»»

Category: topSource: newsweekApr 27th, 2018

Kidney disease treatment with roots in KC wins approval after 36 years

The Food and Drug Administration gave the green light for the first approved treatment for polycystic kidney disease on Tuesday — a treatment based on research that traces its roots to Kansas City. In the 1960s, late University of Kansas Medical .....»»

Category: topSource: bizjournalsApr 25th, 2018

Why Some Investors May Still Look at Prothena, But With Very Different Views

Creating a treatment for a rare disease or rare disorder can come with massive upside if the treatment is successful. That said, the risk is that a company can implode if its rare disease treatment........»»

Category: blogSource: 247wallstApr 23rd, 2018

Alzheimer’s Disease Risk Significantly Reduced in Skin Cancer Survivors, but We Don’t Know Why

It's not yet clear why skin cancer survivors had a dramatically reduced risk of developing Alzheimer's disease......»»

Category: topSource: newsweekApr 20th, 2018

College-Educated People Develop Dementia Later in Life, New Study Suggests

14 million Americans are expected to have Alzheimer's by 2050......»»

Category: topSource: newsweekApr 18th, 2018

Carl Kasell, longtime NPR newscaster, dead at 84

Carl Kassell, a fixture on NPR for more than 30 years on "Morning Edition" and later its quiz show "Wait Wait ... Don't Tell Me!," died Tuesday from complications from Alzheimer's disease. He was 84......»»

Category: topSource: moneyApr 17th, 2018